– Octapharma presenta nuevos datos en ISTH 2023 en una apuesta continua por mejorar la vida de las personas con trastornos de la coagulación LACHEN, Suiza, 7 de junio de 2023 /PRNewswire/ — Octapharma presentará nuevos hallazgos clínicos y científicos para wilate®, Nuwiq®, octaplex® y atenativ® en el próximo Congreso ISTH 2023 Los nuevos datos … Read more
HALIFAX, NS, June 7, 2023 /PRNewswire/ — Densitas® Inc., a global provider of A.I. solutions for digital mammography and breast screening, today announced a strategic partnership with ScreenPoint Medical, a developer of innovative breast imaging solutions. The companies will work together to increase the reach of their industry-leading AI solutions, transforming the delivery of care … Read more
Společnost iHerb uspořádala v Rijádu společnou slavnostní akci, na které oznámila vznik nového partnerství za účelem vybudování prvního centra pro elektronický obchod v Saúdské Arábii IRVINE, Kalifornie, 7. června 2023 /PRNewswire/ – Společnost iHerb, celosvětový lídr v oblasti zdraví a wellness, s potěšením oznamuje navázání partnerství se společností CJ Logistics, lídrem v oblasti logistických řešení, … Read more
EVANSVILLE, Ind., June 7, 2023 /PRNewswire/ — One of the fastest growing Crunch franchisees, Fitness Ventures LLC, opened its newest location, Crunch Evansville on April 28, 2023. A $5 million, 35,000-square-foot fitness facility, with $1 million dollars worth of state-of-the-art equipment. Crunch is located at 306 N Green River Rd, Evansville, IN. Opening month has … Read more
NEW YORK, June 7, 2023 /PRNewswire/ — Royal Health Inc., a leading provider of healthcare software and services, is pleased to announce the establishment of its new subsidiary, RoyalAi Inc. This innovative unit specializes in harnessing the power of artificial intelligence (AI) to enhance operational decision-making processes within the radiology and adjacent markets. RoyalAi has … Read more
HealthDyne partners with Cost Plus Drugs to further lower costs and expand access to affordable prescription medications for those living with chronic diseases. LAKELAND, Fla., June 7, 2023 /PRNewswire/ — Ongoing changes in the healthcare industry have fueled innovators to reinvent the future, forge new paths, make smart decisions, and find aligned partners to disrupt … Read more
CloudFabrix showcases the Power and Extensibility of the Cisco FSO Platform, with Data Modernization, and Composable Dashboards for Applications Telemetry LAS VEGAS, June 7, 2023 /PRNewswire/ — Today at Cisco Live, Cisco’s annual IT and communications conference, CloudFabrix, the inventor of Robotic Data Automation Fabric (RDAF) and the “Data-centric AIOps” leader announced the launch of Observability Data … Read more
Durable remissions observed in patients relapsed or refractory to prior venetoclax-based regimens Data featured in a poster presentation at the European Hematology Association (EHA) 2023 Hybrid Congress SOUTH SAN FRANCISCO, Calif., June 7, 2023 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced promising data from an analysis of the Phase 2 study evaluating REZLIDHIA® … Read more
Funding supports clinical development of first therapeutic candidate and pipeline expansion Marie-Claire Peakman, PhD, Partner, Pfizer Ventures, and Jasmina Marjanovic, PhD, Director AbbVie Ventures, to join Mozart’s Board of Directors SEATTLE, June 7, 2023 /PRNewswire/ — Mozart Therapeutics, a leading developer of CD8 Treg Modulators for the treatment of autoimmune and inflammatory diseases, today announced … Read more
A Yxintent venderá exclusivamente o Lafullen® após realizar estudos clínicos e receber aprovação na China, com a Samyang fornecendo produtos no valor de KRW 100 bilhões nos próximos cinco anos Enchimento dérmico biodegradável de longa duração com volume natural e efeitos duradouros, segurança e eficácia comprovadas Obteve aprovação na Indonésia em abril, expandindo para o mercado … Read more